The Department of Labor proposed a rule Wednesday allowing “religion-exercising organizations” with federal contracts to raise religious exemptions if accused of bias in their hiring practices.
Proposed rule would cement religious exemptions from bias claims. Move raises LGBT worker protection concerns
Powerful Ugandan politician Winnie Byanyima has today Wednesday agreed to step down as Oxfam boss
UNAIDS warmly welcomes the appointment of Winnie Byanyima as its new Executive Director. Ms Byanyima has more than 30 years of experience in political leadership, diplomacy and humanitarian engagement.
Members of key populations experience disproportionate burdens of both HIV and violence. These epidemics are linked—violence increases HIV vulnerability and poses a barrier to HIV testing, disclosure and adherence to antiretroviral therapy.
After transgender woman Gretchen Diez was rejected from using the bathroom on the basis of sex, Senator Risa Hontiveros renewed her call for Congress to pass the SOGIE equality bill.
A group of lawmakers in the House of Representatives has called for an investigation on the alleged discrimination against a transgender woman in a Quezon City mall.
The janitress who prevented Diez from using a women's restroom drops her complaint against Diez, but the transgender woman vows to 'pursue legal action'
TWO male penguins have adopted an egg that was abandoned and have been caring for it since July at a zoo in Berlin, Germany.
With its concentrated HIV epidemic, the Middle East and North Africa has the advantage of a relatively low HIV burden among the general population, as well as among children and adolescents.
Chao Xiaomi says there is still a serious lack of LGBT education in China, and wants to reach out to its smallest and most traditional communities. A gender reassignment surgeon says the medical community also lacks understanding, and criteria for surgery can be tough for patients to meet.
The possibility of new PrEP drug raises questions about how to fix gaps in data on women. Medicare will cover CAR-T cell therapy with significant moves to broaden administration and eligible patients. Sarepta denies a serious patient response to its Duchenne’s therapy, but its stock plunges.